XML 25 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
Statements of Cash Flows (USD $)
12 Months Ended 74 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Dec. 31, 2011
Operating Activities:        
Net loss $ (105,743,860) $ (31,233,718) $ (20,922,717) $ (183,006,936)
Adjustments to reconcile net loss to cash used in operating activities:        
Depreciation and amortization 7,541,962 6,690,601 2,582,706 18,347,024
Stock based compensation 1,572,607 2,713,468 2,676,957 11,887,377
Common stock issued for services 58,950 0 0 58,950
Realized gain (loss) on forward contracts (63,915) 0 1,128,326 1,430,766
Unrealized gain on forward contracts 0 0 (766,403) 0
Foreign currency transaction gain (loss) (145,940) 180,621 (586,555) (595,799)
Charge off of deferred financing costs to interest expense 0 0 0 198,565
Charge off of bridge loan discount to interest expense 0 0 0 800,000
Impairment loss 78,000,000 1,769,480 0 79,769,480
Contract cancellation loss 590,774 0 0 590,774
Changes in operating assets and liabilities:        
Accounts receivable 142,939 (351,180) 202,389 (342,087)
Related party receivables 2,524 19,046 (21,570) 0
Inventories (592,289) (1,638,025) (238,809) (2,469,123)
Prepaid expenses and other current assets 123,724 68,472 167,868 (386,624)
Accounts payable (433,844) 399,893 427,143 658,605
Related party payable (53,808) (141,917) (67,327) 229
Accrued expenses (691,346) (341,024) 1,205,431 1,119,505
Deferred revenue (250,705) 250,705 0 0
Warranty reserve 10,760 15,900 0 26,660
Net cash used in operating activities (19,931,467) (21,597,678) (14,212,561) (71,912,634)
Investing Activities:        
Purchases of available-for-sale-securities (28,215,821) (38,601,173) (143,989,514) (906,480,255)
Maturities and sales of available-for-sale securities 33,087,378 59,906,220 157,003,665 893,865,178
Purchase of property, plant and equipment (9,681,565) (5,576,874) (7,049,400) (48,571,392)
Deposits on manufacturing equipment 0 (5,388,160) (38,566,459) (79,883,404)
Restricted cash for manufacturing equipment 1,832,297 (3,259,350) 2,300,000 (1,427,053)
Patent activity costs (60,408) (98,084) (34,365) (312,076)
Deposit on building 0 0 0 (100,000)
Net cash provided by (used in) investing activities (3,038,119) 6,982,579 (30,336,073) (142,909,002)
Financing Activities:        
Proceeds from bridge loan financing 0 0 0 1,600,000
Repayment of bridge loan financing 0 0 0 (1,600,000)
Payment of debt financing costs 0 0 0 (273,565)
Payment of equity offering costs 0 (1,409,937) (2,062,866) (10,302,040)
Proceeds from debt 0 0 262,948 7,700,000
Repayment of debt (582,257) (217,463) (187,151) (1,186,871)
Repayment of debt-related party 0 (350,000) 0 (350,000)
Proceeds from shareholder under Section 16(b) 0 0 0 148,109
Proceeds from issuance of stock and warrants 7,547,511 22,178,501 35,339,614 230,433,016
Redemption of Class A warrants 0 0 0 (48,128)
Net cash provided by (used in) financing activities 6,965,254 20,201,101 33,352,545 226,120,521
Net change in cash and cash equivalents (16,004,332) 5,586,002 (11,196,089) 11,298,885
Cash and cash equivalents at beginning of period 27,303,217 21,717,215 32,913,304 0
Cash and cash equivalents at end of period 11,298,885 27,303,217 21,717,215 11,298,885
Supplemental Cash Flow Information:        
Cash paid for interest 113,471 0 0 113,895
Cash paid for income taxes 0 0 0 0
Non-Cash Transactions:        
ITN initial contribution of assets for equity 0 0 0 31,200
Note with ITN and related capital expenditures $ 0 $ 1,100,000 $ 0 $ 1,100,000